| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:30 | Alkane Resources secures A$150m in new credit facilities | ||
| So | Jefferies initiates Vor Biopharma stock with buy rating on autoimmune pivot | ||
| So | Goldman Sachs reiterates Pony AI stock rating on robotaxi growth | ||
| So | Bristol Myers Squibb's Camzyos shows promise in adolescent trial | ||
| So | Merck's Winrevair meets primary endpoint in heart failure trial | ||
| So | JPMorgan upgrades HDFC Bank stock rating on valuation appeal | ||
| So | Breaking down Toyota's EV counterattack | ||
| So | InSilico, Lilly ink AI drug discovery deal worth up to $2.75 billion | ||
| So | Why a Coding Agent May Emerge as a Key Unlock for Growth | ||
| Sa | Lilly's Taltz plus Zepbound shows efficacy in psoriatic arthritis trial | ||
| Sa | Biogen reports positive Phase 2 results for lupus skin drug | ||
| Sa | Priovant reports positive dermatomyositis trial results in NEJM | ||
| Sa | BofA previews Apple's first foldable iPhone | ||
| Sa | Alumis reports Phase 3 psoriasis trial results for envudeucitinib | ||
| Sa | Banco Comercial Português 2025 slides: net income tops €1B, ROE hits 14.1% | ||
| Sa | Nektar presents rezpegaldesleukin data at dermatology meeting | ||
| Sa | Sanofi reports positive phase 3 data for atopic dermatitis drug | ||
| Sa | Arcutis presents trial data on roflumilast cream for infants | ||
| Sa | Protagonist presents one-year data for psoriasis drug ICOTYDE | ||
| Sa | Maersk halts operations at Oman's Salalah port after security incident | ||
| Sa | Garanti BBVA agrees to sell Romanian unit for €591 million | ||
| Sa | Analyst compares Apple's strategy to what Samsung did in the past | ||
| Sa | Federal judge halts Nexstar-Tegna merger following antitrust challenge | ||
| Sa | Brava Q4 2025 slides: record production masks earnings disappointment | ||
| Sa | PubMatic Q4 2025 slides: 35% EBITDA margin amid AI transformation |